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In-cell NMR is a unique approach to observe the structural and dynamic properties
of biological macromolecules at atomic resolution directly in living cells. Protein
folding, chemical modifications, and conformational changes induced by ligand binding
can be observed. Therefore, this method has great potential in the context of drug
development. However, the short lifetime of human cells confined in the NMR
spectrometer limits the application range of in-cell NMR. To overcome this issue,
NMR bioreactors are employed that can greatly improve the cell sample stability
over time and, importantly, enable the real-time recording of in-cell NMR spectra.
In this way, the evolution of processes such as ligand penetration and binding to
the intracellular protein target can be monitored in real time. Bioreactors are often
limited by low cell viability at high cell numbers, which results in a trade-off between
the overall sensitivity of the experiment and cell viability. We recently reported an
NMR bioreactor that maintains a high number of human cells metabolically active for
extended periods of time, up to 72 h. This setup was applied to monitor protein-ligand
interactions and protein chemical modification. We also introduced a workflow for
quantitative analysis of the real-time NMR data, based on multivariate curve resolution.
The method provides concentration profiles of the chemical species present in the
cells as a function of time, which can be further analyzed to obtain relevant kinetic
parameters. Here we provide a detailed description of the NMR bioreactor setup and
its application to monitoring protein-ligand interactions in human cells.
Introduction
In-cell Nuclear Magnetic Resonance (NMR) spectroscopy
has recently emerged as a powerful approach to investigate
structural and dynamical properties of macromolecules within
the cellular environment1,2 ,3 ,4 ,5 ,6 . In-cell NMR succeeded
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in the investigation of functionally relevant processes such as
protein folding/misfolding7,8 ,9 , metal binding7,10 , disulfide
bond formation11,12 , and protein−protein interaction13 ,
protein-ligand interaction14,15 ,16 , and nucleic acid-ligand
interaction17,18  in living human cells. One of the limiting
factors of in-cell NMR applications is the short lifetime of
the cells during the experiment. The solution to this problem
involves the use of NMR bioreactors. In these devices, a
constant flow of growth medium is applied to the cells, which
are kept confined within the NMR spectrometer, in order to
provide oxygen and nutrients and to remove toxic byproducts.
Following the advent of in-cell NMR, several NMR bioreactors
designs have been developed to improve cell viability for
longer periods of time, in which either bacteria or mammalian
cells are encapsulated in a hydrogel19,20 ,21 ,22  or kept in
suspension and perfused through the use of a microdialysis
membrane23 . Such bioreactors have allowed the acquisition
of longer NMR experiments with increased signal-to-noise
ratio (S/N)5  and, even more importantly, could be employed to
investigate cellular processes in real time22,23 ,24 . Thanks to
the high chemical and conformational sensitivity of NMR, the
latter application can provide precious insights on the kinetics
of functional processes within living cells at atomic resolution.
In this protocol, we show how to set up and operate an
improved bioreactor recently reported25 , which was obtained
by combining an existing modular bioreactor design23  with
the approach relying on cell encapsulation in hydrogel
that were pioneered by other groups19,20 ,21 ,22 ,26 ,27 . We
describe the application of the bioreactor to real-time in-cell
NMR studies of intracellular protein-observe ligand binding
in HEK293T cells. In the bioreactor, cells are encapsulated
at high density in agarose gel threads and are maintained
highly viable and metabolically active for up to 72 h, during
which real-time in-cell NMR experiments are recorded. The
bioreactor is composed of a glass tube that fits standard 5 mm
NMR probes that is watertight and connected to a tube holder
so that the internal sample chamber has 4.2 mm internal
diameter, 38 mm height, and a volume of 526 µL. The inlet
is a 7-meter-long PEEK capillary (o.d. = 1/32", i.d. = 0.5 mm)
inserted in the sample chamber down to ~6 mm from the
bottom, while the outlet is a 7-meter-long PTFE capillary (o.d.
= 1/32", i.d. = 0.5 mm) attached at the top of the tube holder
(Figure 1). The tubing is coaxially inserted in a temperature-
controlled line connected to a water bath. The inlet and outlet
are connected through PEEK tubing to a 4-way, 2-position
valve attached to an FPLC pump for controlling the medium
flow and a waste container.
The bioreactor is applied to study the kinetics of the
interaction, previously reported14,25 , between two drugs,
acetazolamide (AAZ) and methazolamide (MZA), in human
cells with the second isoform of human carbonic anhydrase
(CA II), a pharmacologically relevant target28,29 ,30 , and the
kinetics of the formation of the intramolecular disulfide bond,
promoted by the small molecule ebselen25,31 , of the copper-
free, zinc-bound form of human copper, zinc superoxide
dismutase (SOD1), an antioxidant enzyme implicated in
the onset of amyotrophic lateral sclerosis7,8 ,32 . Finally,
quantitative analysis of the real-time NMR data is performed
in MATLAB using the Multivariate Curve Resolution-
Alternating Least Squares (MCR-ALS) algorithm33 , through
which the pure spectral components and the concentration
profiles as a function of time are obtained for the species
observed, that can be further analyzed to obtain relevant
kinetic parameters.
The protocol starts from a T75 flask of HEK293T cells (~3 x
107  cells per flask) transiently overexpressing either human
CA II (unlabeled) or human SOD1 (15N-labeled). The cells
Copyright © 2021  JoVE Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported
License
jove.com March 2021 • 169 •  e62323 • Page 3 of 17
were grown and maintained in T75 flasks with DMEM high
glucose by 1:10 passages every 3-4 days and transfected
with the cDNA encoding the protein of interest 48 h prior to
the experiment. The steps involved in this phase are reported
in detail elsewhere34 .
Protocol
1. Reagent and solution setup
1. To prepare complete DMEM, add 5 mL L-glutamine 200
mM, 5 mL penicillin-streptomycin 100x, and 50 mL fetal
bovine serum (FBS, 10% vol/vol final concentration) to
440 mL DMEM.
 
NOTE: This solution can be stored at 4 °C for 1 month.
2. Prepare agarose solution by dissolving 150 mg of low-
gelling agarose in 10 mL of phosphate buffered saline
(PBS) at 85 °C to obtain a 1.5% (w/v) solution. Sterilize
by filtration with a 0.22 µm filter. Prepare 1 mL aliquots
of agarose solution in 1.5 mL capped tubes and store at
4 °C.
3. Prepare the bioreactor medium.
1. Dissolve 13.4 g of DMEM powder in 1 L of ultrapure
H2O.
 
NOTE: Depending on the application, the required
final volume may differ (e.g., for 500 mL medium,
dissolve 6.7 g of powder in 500 mL H2O).
2. Add 2% FBS, 10 mM NaHCO3, 1x penicillin-
streptomycin (100x), and 2% D2O (e.g., for 500 mL
medium, add 10 mL of FBS, 0.4 g of NaHCO3, 5 mL
of penicillin-streptomycin 100x, and 10 mL of D2O).
3. Measure the pH using a pH-meter and if needed
adjust to 7.4 by adding HCl.
 
NOTE: Typically, the initial pH is very close to 7.4.
4. Filter the bioreactor medium with a vacuum-driven
sterile filter in a sterile 250 mL or 500 mL glass bottle.
5. In the laminar flow hood, seal the bottle with a sterile
steel headpiece with two hose nozzles and connect
them to a FEP tubing (o.d. = 1/8", i.d. = 1.6 mm)
that will be connected to the pump and to a 0.22 µm
PTFE syringe filter for air intake.
2. Bioreactor setup
1. Assemble the flow unit using a second flow unit NMR
tube, which will be later replaced with the one containing
the cells. Refer to the flow unit operating instructions for
the correct assembly.
 
NOTE: At this point the flow unit should be already
cleaned (if not, perform step 4.2).
2. Set the water bath connected to the flow unit temperature
control to 37 °C. Place the reservoir bottle in the water
bath.
3. Connect the FEP tubing of the reservoir bottle to the
pump.
4. Turn the bioreactor valve to "bypass" and prefill the pump
with medium.
5. Turn the bioreactor valve to "flow" and prefill the
bioreactor with medium at 0.1 mL/min.
3. Preparation of the cell sample
1. Collect the cells from the CO2 incubator.
1. Take a T75 flask of transfected HEK293T cells from
the CO2 incubator and remove the spent medium.
2. Wash the cells twice with 7 mL (each) of PBS at room
temperature (~20 °C).
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3. Use 2 mL of trypsin/EDTA to detach cells. After
adding the solution, incubate for 5 min at room
temperature to detach the cells.
 
NOTE: Transfected cells may take slightly longer to
get detached. If necessary, incubate the cells at 37
°C.
4. Inactivate trypsin with 20 mL of complete DMEM;
thoroughly resuspend the cells by pipetting up and
down and transfer them in a 50 mL centrifuge tube.
5. Centrifuge the cells at 800 x g for 5 min at room
temperature and discard the supernatant.
6. Wash the cells with 10 mL of PBS at room
temperature to remove the residual medium.
7. Centrifuge the cells at 800 x g for 5 min at room
temperature and discard the supernatant.
8. Transfer the cell pellet to a 1.5 mL capped
microcentrifuge tube.
2. Embed cells in agarose threads.
1. Melt one aliquot of solidified agarose at 85 °C in a
water bath and subsequently keep it in solution at 37
°C in a block heater.
2. With a Pasteur pipette, fill the bottom of the flow unit
NMR tube with 60-70 µL of 1.5% agarose gel and
place it in ice. This will create a ~5 mm high bottom
plug that allows placing the cell sample within the
active volume of the 1H NMR coil.
3. Heat up the pellet of cells obtained in step 3.1.8 at
37 °C for 15−20 s in the thermoblock.
4. Resuspend cells in 450 µL of agarose solution. Be
careful to avoid the formation of bubbles.
5. Aspirate the cell−agarose suspension into a ~30 cm
long chromatography PEEK tubing (i.d. = 0.75 mm)
connected to a 1 mL syringe.
 
NOTE: Before aspiration, the tubing and the dead
volume of the syringe should be prefilled with PBS at
room temperature to avoid the formation of bubbles.
The length of the tubing is not critical.
6. Let the tubing cool down at room temperature for 2
min.
7. Prefill the flow unit NMR tube with 100 µL of PBS at
room temperature.
8. Cast threads of cells embedded in agarose into the
flow unit NMR tube by gently pushing the syringe.
 
NOTE: To fill the NMR tube homogenously, start by
placing the end of the PEEK tubing at the bottom
of the NMR tube and proceed towards the top while
slowly swinging left-right.
9. Repeat steps 3.2.5, 3.2.6, and 3.2.8 until all the cell-
agarose suspension has been cast.
3. Insert cells in the bioreactor.
1. Remove the empty NMR tube from the flow unit and
increase the flow rate to 2 mL/min for a few minutes
to remove residual gas bubbles in the inlet tubing.
2. Set the flow rate to 0.2 mL/min and insert the NMR
tube containing the cells by pushing it upwards
slowly but steadily.
 
NOTE: The active flow of medium avoids the
backflow of tube content through the inlet, that would
otherwise occur during the insertion.
4. Bioreactor operation and cleaning
1. Bioreactor operation during the NMR experiment.
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1. Set the temperature in the NMR spectrometer to 310
K.
2. Insert the flow unit in the spectrometer.
3. Supply the bioreactor medium at a flow rate of 0.1
mL/min for the whole duration of the in-cell NMR
experiments.
4. At the desired time during the experiment, inject a
concentrated solution of external molecule to the
medium reservoir bottle by piercing the silicone
tubing with a sterile long-needle syringe.
 
NOTE: The final concentration of molecule in the
medium should be chosen based on previous
knowledge of cell toxicity and, if available, on the
predicted/estimated diffusion rate through the cell
membrane.
5. At the end of the NMR experiment, replace the tube
containing the cells with an empty tube and rinse the
flow unit with water.
2. Bioreactor clean-in-place.
1. Clean the flow unit by flowing the following solutions
at 1 mL/min: 0.2 M sodium hydroxide (NaOH); 3 M
citric acid; 0.2 M NaOH, for at least 30 min each,
followed by sterile-filtered ultrapure water for >2 h.
2. Clean and autoclave the reservoir bottle and tubing
assembly after each run.
5. NMR experiments
1. Setup of the NMR experiments.
 
NOTE: Perform these steps beforehand, prior to the
preparation of the in-cell NMR sample, to avoid any
delays between cell collection and data acquisition.
1. Create a new dataset at the NMR spectrometer
and set the parameters for the desired NMR
experiments.
2. Set parameters for 1D 1H NMR experiments.
3. Center the 1H carrier frequency at 4.7 ppm on the
water signal.
4. Select the zgesgp pulse program, set the spectral
width to 20 ppm, and a 1,000-µs 180° square pulse
for water suppression. Set an inter-scan delay of 1
s. Acquire the spectrum with 32 scans.
5. For cells expressing unlabeled CA II: select the
p3919gp pulse program, set the spectral width to
30 ppm to cover the imino region of the spectrum,
and adjust the delay for binomial water suppression
so that the maximum excitation is centered at the
chemical shifts of the signals of interest (d7 = 20 µs
at 950 MHz). Set an inter-scan delay of ≥1 s. Acquire
with 512 scans.
6. For cells expressing 15N-labeled SOD1: select the
sfhmqf3gpph pulse program, set the 1H and 15N
spectral widths to 16 and 50 ppm, respectively, the
shaped pulse offset and excitation bandwidth to 8.5
and 6 ppm, respectively, and a 350 µs pulse for
decoupling scheme (garp4 or other depending on
the instrument). Set an inter-scan delay of 0.3 s.
Acquire with 16 scans and 128 increments in the 15N
dimension.
2. Real-time NMR spectra acquisition.
1. Once the bioreactor is inserted in the NMR
spectrometer, wait for a few minutes to allow the
exchange of the medium.
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NOTE: This process is easily monitored from the
appearance of the lock signal as the PBS is replaced
with medium containing 2% D2O.
2. Adjust the matching and tuning of the 1H channel,
shim the magnet, and calculate the 1H 90° hard
pulse length.
3. Adjust the 1H power levels in each pulse sequence
according to the 1H hard pulse.
4. Record a first zgesgp 1H spectrum to check the
sample content and the field homogeneity.
5. Copy the zgesgp and the p3919gp/sfhmqcf3gpph
experiments to the desired number and queue them
in the acquisition spooler.
 
NOTE: The zgesgp spectra are only used to control
the state of the sample and the field homogeneity;
therefore, they can be either skipped or recorded
less frequently.
6. For cells expressing unlabeled CA II: process
the p3919gp spectra by applying zero filling and
exponential line broadening window function (LB =
20 Hz).
7. For cells expressing 15N-labeled SOD1: process the
sfhmqcf3gpph spectra by applying zero filling and
squared sine bell window function (SSB = 2) in both
dimensions.
 
NOTE: The size of the processed spectra can be
further reduced by removing regions free of signals
(in Topspin, this is done by setting the desired STSR
and STSI values).
6. MCR-ALS analysis
1. For the analysis of CA II spectra, import 1D spectral
regions in MATLAB R2019b.
1. In the software, create a list of experiments to be
exported in the Process Dataset List menu.
2. Using a modified version of the au program
convbin2asc, export the spectral region of interest in
ASCII format for each spectrum.
 
NOTE: This creates a text file named ascii-spec.txt
in each spectrum subdirectory.
3. In MATLAB, import the spectral regions using the
custom script Load_ascii_spectra.
 
NOTE: This script requires the dataset directory as
an input and produces a 2D array spectra containing
the stacked 1D spectra and a 1D array cs containing
the chemical shifts.
4. Run the Load_acqus script to extract the timestamps
from the 1D spectra.
 
NOTE: This script produces a 1D array times_hours
containing the time increment for each spectrum
expressed in hours, with the initial spectrum at time
= 0.
2. For the analysis of SOD1 spectra, import 2D spectra in
MATLAB R2020b.
1. In Topspin, create a list of experiments to be
exported in the Process Dataset List menu.
2. In MATLAB, import the 2D spectra using the custom
script Load_2D_spectra.
 
NOTE: This script requires the dataset directory as
an input and produces a 3D array Spectra containing
the stacked 2D spectra and a 1D array cs containing
the chemical shifts.
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3. Run the Load_acqus script to extract the timestamps
from the 2D spectra.
4. Specify the spectral regions of interest in the custom
script Cut_2D_spectra and run the script to cut 3D
sub-arrays [(1H x 15N) spectral intensities) x time];
reshape them as 2D arrays (time points x spectral
intensities) and join them together.
 
NOTE: This produces a 2D array JoinSpec_flat
containing the reshaped and joined spectral regions.
3. Run MCR-ALS 2.0 in GUI mode.
1. Open MCR-ALS 2.0 GUI by running the mcr_main
script.
2. In the Data Selection tab, load the spectra or the
JoinSpec_flat matrix. The data can be plotted for
checking.
3. Evaluate the number of components either by
Singular Value Decomposition (SVD) or manually.
 
NOTE: The number of components should
correspond to the number of distinct species present
in the experiment. In this case n = 2, corresponding
to the free and bound protein.
4. Select a method for the initial estimation of the pure
spectra. Either purest variable detection or Evolving
Factor Analysis (EFA) can be used.
5. In the Selection of the Data Set window, select
Continue.
6. Set the constraints for the concentrations
in the Constraints: Row Mode window.
Apply a non-negativity constraint, select fnnls
(Fast nonnegativity-constrained least-squares) as
"implementation and 2 species". Apply 1 closure
constraint, set the constraint to 1, the closure
condition as "equal to" and apply to all species.
 
NOTE: This forces the sum of each species
concentrations to be equal to 1, so that the obtained
profiles of each species are normalized with respect
to the total protein concentration.
7. Set the constraints for the spectra in the
Constraints: Column Mode window. Apply a non-
negativity constraint, select fnnls as "implementation
and 2 species".
 
NOTE: This constraint should not be applied if
negative signals are present in the NMR spectra.
8. In the final window, set 50 iterations and 0.01
convergence criterion. Specify the output names for
Concentrations, Spectra, and Std. deviation. Click
on Continue to run the MCR-ALS fitting.
 
NOTE: A graphical window will show the result of the
fitting with plots of the concentration profiles and the
spectra of the pure components.
9. For the SOD1 dataset: use the custom script
Rebuild_2D_spectra to reconstruct the 2D spectral
regions from the 1D output of MCR-ALS and plot
them.
7. Trypan blue test
1. Recover the NMR tube content with a Pasteur pipet, and
transfer the agarose threads to a 1.5 mL capped tube.
2. Remove the residual medium by rinsing the agarose
threads with 600 µL of PBS and centrifuge them at
4,000 x g for 1 min at room temperature. Discard the
supernatant.
3. Add 250 µL of PBS and 50 µL of 0.4% Trypan blue
solution.
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4. Incubate for 2 min with continuous pipetting.
5. Wash twice with 600 µL of PBS discarding the
supernatant.
6. Place a few agarose threads on a microscope slide and
chop them with razor blades to create small slices of gel.
Select the thinnest slices (thickness < 0.4 mm, ideally
~0.2 mm) for the analysis.
7. Transfer the gel slices into a self-made cell counting
chamber consisting of two glass slides spaced by three
layers of paraffin film (~0.4 mm total thickness) on each
side.
 
NOTE: A chamber slide could also be used; however,
the gel slices thicker than the chamber height (0.1 mm)
would be squeezed, rupturing the embedded cells.
8. Acquire images of cells inside the agarose and count
white and blue cells.
9. Calculate cell viability as (total cells - blue cells) / total
cells.
Representative Results
The above protocol allows the encapsulation of cells in
threads of hydrogel to maximize cell viability for long periods
of time, necessary to investigate in real time intracellular
processes. In the bioreactor, the cells are maintained alive
and metabolically active up to 72 h, as confirmed by
Trypan blue test (Figure 2a-c). In principle, this protocol
can be applied to observe an intracellular protein of interest
undergoing any conformational or chemical changes. In the
first application described above, the bioreactor is applied to
monitor in real time the binding of two inhibitors, AAZ and
MZA, to CA II overexpressed in the cytosol of HEK293T
cells. The first 1H excitation sculpting spectrum (zgesgp)
recorded is used to assess the overall signal intensity (which
is proportional to the number of cells), the presence of signals
from the overexpressed protein and the field homogeneity
(Figure 2d). In the case of CA II, the intracellular binding of the
two inhibitors can be monitored by WATERGATE 3-9-1935
1D 1H NMR spectra (p3919gp), by observing 1H signals in
the region between 11 and 16 ppm. These signals arise from
the zinc-coordinating histidines and other aromatic residues
of CA II36  and are perturbed upon ligand binding14,15 .
Ligand concentrations can be chosen based on the diffusion
rate or, if available, from previously determined permeability
values14 . Successful binding is confirmed visually by the
appearance of an additional set of signals in the spectral
region of interest, that gradually replaces the original signals
(Figure 3). Time-dependent binding curves are obtained
by MCR-ALS analysis, which separates the two sets of
NMR signals arising from free and bound CA II (Figure
4a) and simultaneously provides the relative concentration
profiles of the two species (Figure 4b). In the second
application, the bioreactor is applied to monitor the formation
of zinc-bound SOD1 intramolecular disulfide bond promoted
by ebselen, a glutathione peroxidase mimetic, in human
cells. This process is monitored by observing changes in
1H-15N 2D SOFAST-HMQC37  spectra (which provides a
fingerprint of the protein backbone conformation) caused
by perturbations of the protein structure induced by the
disulfide bond formation. Additional signals arising from
disulfide-oxidized SOD1 appear in the 1H-15N spectrum
and gradually replace those from disulfide-reduced SOD1.
MCR-ALS analysis on selected regions of the 2D spectrum
separates the signals arising from the two species (Figure 5a)
and provides their relative concentration profiles (Figure 5b).
The obtained concentration curves can be further analyzed
by non-linear fitting to provide information on the kinetics of
the processes under study25 .
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Figure 1: Scheme of the bioreactor. Left: cross-section view of the empty flow unit. Right: scheme of the bioreactor
setup. The PEEK inlet tubing is shown in green; the PTFE outlet tubing is shown in blue. The left panel is reproduced with
permission from Luchinat et al.25 . Please click here to view a larger version of this figure.
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Figure 2: Trypan Blue Test on encapsulated cells and sample check by 1H NMR. Representative slices of agarose
containing embedded cells and stained with Trypan blue (a) immediately after casting and (b) after 72 h in the bioreactor; (c)
cell viability as a function of time in the NMR bioreactor under active flow (black) and under static conditions (red), measured
by Trypan Blue Test. (d) zgesgp 1H NMR spectra recorded on agarose-embedded cells overexpressing CA II in the absence
(black) and in the presence (red) of gas bubbles in the bioreactor. In the latter case, decreased field homogeneity causes line
broadening and the appearance of solvent suppression artifacts. Interesting spectral features are labeled. Panels (a-c) are
reproduced with permission from Luchinat et al.25 . Please click here to view a larger version of this figure.
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Figure 3: Representative real-time in-cell 1H NMR data obtained on agarose-encapsulated cells in the bioreactor.
Waterfall plots of 1D 1H NMR spectra (region between 15.6 and 11.1 ppm) of HEK293T cells overexpressing CA II and
subsequently treated with (a) 25 µM AAZ and (b) 10 µM MZA, recorded as a function of time in the NMR bioreactor. The time
of ligand treatment is shown with an arrow. Spectral intensity (a.u.) is color-coded from blue (lowest) to yellow (highest). This
figure is reproduced with permission from Luchinat et al.25 . Please click here to view a larger version of this figure.
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Figure 4: Representative MCR-ALS output from 1D NMR spectra. (a) 1H NMR spectra of the pure components
reconstructed by MCR-ALS: CA II in the absence of ligands (black) and in the complex with AAZ (red) or MZA (magenta);
(b) relative concentration profiles of free (black) and bound CA II as a function of time upon addition of AAZ (red) or MZA
(magenta) obtained by MCR-ALS. Times of ligand treatment are marked with arrows. This figure is reproduced with
permission from Luchinat et al.25 . Please click here to view a larger version of this figure.
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Figure 5: Representative MCR-ALS output from 2D NMR spectra. (a) 1H-15N spectral regions (labeled I-IV) of the pure
components reconstructed by MCR-ALS: disulfide-reduced SOD1 (black) and disulfide-oxidized SOD1 (red); (b) relative
concentration profile of the pure components as a function of time upon addition of ebselen (marked with an arrow) obtained
by MCR-ALS. This figure is reproduced with permission from Luchinat et al.25 . Please click here to view a larger version of
this figure.
Discussion
The aim of using a bioreactor for in-cell NMR experiment is
to keep cells alive and metabolically active for a prolonged
period of time. A number of critical aspects must be taken
into consideration to achieve this aim. First, it is paramount
to avoid bacterial contamination when preparing the cell
sample and during the NMR data acquisition. If strains of E.
coli or other bacteria commonly used for gene cloning and
recombinant protein expression are used in the laboratory,
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they may contaminate the cells during sample preparation.
Once in the bioreactor, the bacteria will grow quickly exploiting
the fresh growth medium and will cause cell death due to
the production of endotoxins. Bacterial contamination is only
spotted at an advanced stage, when it turns the growth
medium yellow and turbid. Furthermore, incomplete cleaning
of the bioreactor could cause contamination of the pump or
the tubing with bacteria, yeasts, or common molds.
A requirement for the success of the experiment is the
avoidance of gas bubble formation. Gas bubbles trapped
between the agarose threads in the active volume of the NMR
coil would introduce large magnetic field inhomogeneities,
causing incomplete suppression of the H2O signal and severe
loss of spectral quality (Figure 2d). Bubbles may be caused
by air trapped in the system or by the formation of gaseous
CO2. The former can be easily avoided by flushing the system
with medium prior to inserting the cell sample, while to avoid
the latter it is recommended to decrease the concentration
of NaHCO3 in the growth medium, and to keep all parts of
the system at a constant temperature to minimize differences
in the CO2 solubility. Cellular aerobic metabolism may also
cause the formation of gaseous CO2, which can be prevented
by increasing the flow rate.
Cell viability should be checked after each run by Trypan
Blue Test. However, that does not provide insights on the
metabolic activity. To obtain a more complete picture of the
metabolic state of the cells during the bioreactor operation,
31P NMR spectra can be performed to assess the production
of ATP as a function of time23,25 . However, a dedicated
probe is often necessary for this measurement, which may
allow simultaneous recording with 1H NMR.
In the case of CA II, the presence of well-resolved reporter
signals in an unusual region of the 1H spectrum facilitates
the analysis from simple 1D NMR spectra and does not
require isotope enrichment during protein expression. In
general, other proteins could give rise to 1H signals useful
for monitoring spectral changes in other regions, such as
that typical of the protein hydrophobic core between 0 and
-1 ppm11 ; however, these regions tend to be crowded
for folded proteins larger than ~10 kDa. In this case, as
shown for SOD1, it is preferable to enrich the protein with
15N, by providing uniformly 15N-enriched growth medium
during protein expression, and to monitor real-time changes
in 2D 1H-15N NMR spectra. 2D spectra are imported as
a 2D arrays in MATLAB, rearranged to 1D arrays and
stacked prior to MCR-ALS analysis. The latter approach is
generally applicable to any intracellular protein that gives
rise to detectable signals, and provides information on
protein conformational changes at the single residue level. In
principle, the latter approach can be generalized to nD spectra
and to other isotope-labeling schemes.
Concerning the application to different types of cells, the
protocol should be easily adapted to different cell lines
and does not require that the protein of interest is directly
expressed in the cells. Therefore, other approaches to in-
cell NMR can be combined with this protocol, in which
the macromolecule of interest is produced recombinantly,
or synthesized, and subsequently inserted into the cells by
electroporation or by other delivery methods1,9 ,38 . When
working with different cell lines or sample preparation
protocols, parameters such as the agarose concentration, the
thread thickness, and the final cell density in the agarose
threads may need to be optimized empirically. Furthermore,
the applicability of the protocol described here is limited
to cells that tolerate agarose encapsulation. Other cell
types may require different hydrogel formulations, whereas
a different setup is recommended when analyzing cells that
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natively grow in suspension, for example, making use of a
coaxial microdialysis membrane to ensure nutrient diffusion
while keeping suspended cells confined in the NMR tube23 .
Compared to other NMR bioreactor designs19,20 ,21 ,22 , the
device described here relies on a commercially available flow-
unit, adapted with minor modifications. Therefore, the device
can be easily replicated in different laboratories with high
reproducibility. Furthermore, it allows standardized operation
and full compliance with strict laboratory safety regulations,
if needed. Overall, the flexibility and ease of operation of the
bioreactor should allow many other applications of solution
NMR, both in cells and in vitro, in addition to those as already
reported23,25 . Eventually, the same bioreactor design could
be applied to samples that resemble more of the physiological
environment of a tissue, such as spheroids or organoids,
provided that appropriate scaffolds are found for keeping such
samples alive-or even sustaining their growth-in the NMR
spectrometer.
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